387 related articles for article (PubMed ID: 17414665)
21. C-reactive protein and aortic stiffness and wave reflection in middle-aged and elderly men from the community.
Nakhai-Pour HR; Grobbee DE; Bots ML; Muller M; van der Schouw YT
J Hum Hypertens; 2007 Dec; 21(12):949-55. PubMed ID: 17597799
[TBL] [Abstract][Full Text] [Related]
22. Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).
Bertoni AG; Wong ND; Shea S; Ma S; Liu K; Preethi S; Jacobs DR; Wu C; Saad MF; Szklo M
Diabetes Care; 2007 Nov; 30(11):2951-6. PubMed ID: 17704348
[TBL] [Abstract][Full Text] [Related]
23. Regional arterial stiffness in patients with type 2 diabetes and chronic kidney disease.
Kimoto E; Shoji T; Shinohara K; Hatsuda S; Mori K; Fukumoto S; Koyama H; Emoto M; Okuno Y; Nishizawa Y
J Am Soc Nephrol; 2006 Aug; 17(8):2245-52. PubMed ID: 16837632
[TBL] [Abstract][Full Text] [Related]
24. Influence of the metabolic syndrome on aortic stiffness in never treated hypertensive patients.
Mulè G; Cottone S; Mongiovì R; Cusimano P; Mezzatesta G; Seddio G; Volpe V; Nardi E; Andronico G; Piazza G; Cerasola G
Nutr Metab Cardiovasc Dis; 2006 Jan; 16(1):54-9. PubMed ID: 16399492
[TBL] [Abstract][Full Text] [Related]
25. The metabolic syndrome in elderly individuals is associated with greater muscular, but not elastic arterial stiffness, independent of low-grade inflammation, endothelial dysfunction or insulin resistance--The Hoorn Study.
Henry RM; Ferreira I; Dekker JM; Nijpels G; Scheffer PG; Stehouwer CD
J Hum Hypertens; 2009 Nov; 23(11):718-27. PubMed ID: 19279658
[TBL] [Abstract][Full Text] [Related]
26. The association of low-grade inflammation, urinary albumin, and insulin resistance with metabolic syndrome in nondiabetic Taiwanese.
Lee IT; Lee WJ; Huang CN; H-H Sheu W
Metabolism; 2007 Dec; 56(12):1708-13. PubMed ID: 17998025
[TBL] [Abstract][Full Text] [Related]
27. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community.
Kullo IJ; Seward JB; Bailey KR; Bielak LF; Grossardt BR; Sheedy PF; Peyser PA; Turner ST
Am J Hypertens; 2005 Aug; 18(8):1123-9. PubMed ID: 16109328
[TBL] [Abstract][Full Text] [Related]
28. Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort.
André P; Balkau B; Vol S; Charles MA; Eschwège E;
Diabetes Care; 2007 Sep; 30(9):2355-61. PubMed ID: 17586745
[TBL] [Abstract][Full Text] [Related]
29. Differential impact of metabolic syndrome on arterial stiffness and wave reflections: focus on distinct definitions.
Vyssoulis GP; Pietri PG; Karpanou EA; Vlachopoulos CV; Kyvelou SM; Spanos P; Cokkinos DV; Stefanadis CI
Int J Cardiol; 2010 Jan; 138(2):119-25. PubMed ID: 18804878
[TBL] [Abstract][Full Text] [Related]
30. Macrovascular and microvascular dysfunction in the metabolic syndrome.
Czernichow S; Greenfield JR; Galan P; Jellouli F; Safar ME; Blacher J; Hercberg S; Levy BI
Hypertens Res; 2010 Apr; 33(4):293-7. PubMed ID: 20075933
[TBL] [Abstract][Full Text] [Related]
31. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
32. Pulse wave velocity in familial combined hyperlipidemia.
ter Avest E; Holewijn S; Bredie SJ; van Tits LJ; Stalenhoef AF; de Graaf J
Am J Hypertens; 2007 Mar; 20(3):263-9. PubMed ID: 17324737
[TBL] [Abstract][Full Text] [Related]
33. Association of adiponectin with procollagen type I carboxyterminal propeptide in non-diabetic essential hypertension.
Tsai WC; Lin CC; Chen JY; Huang YY; Lee CH; Li WT; Weng CM; Chen JH
Blood Press; 2008; 17(4):233-8. PubMed ID: 18671144
[TBL] [Abstract][Full Text] [Related]
34. Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population.
Sung SH; Chuang SY; Sheu WH; Lee WJ; Chou P; Chen CH
Am J Cardiol; 2009 May; 103(10):1411-6. PubMed ID: 19427438
[TBL] [Abstract][Full Text] [Related]
35. Ageing and blood pressure modulate the relationship between metabolic syndrome and aortic stiffness in never-treated essential hypertensive patients. A comparative study.
El Feghali R; Topouchian J; Pannier B; Asmar R
Diabetes Metab; 2007 Jun; 33(3):183-8. PubMed ID: 17336118
[TBL] [Abstract][Full Text] [Related]
36. Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study.
Saltevo J; Vanhala M; Kautiainen H; Kumpusalo E; Laakso M
Diabet Med; 2008 Jun; 25(6):747-50. PubMed ID: 18435780
[TBL] [Abstract][Full Text] [Related]
37. Increased left ventricular arrhythmogenicity in metabolic syndrome and relationship with myocardial performance, risk factors for atherosclerosis, and low-grade inflammation.
Voulgari C; Tentolouris N; Papadogiannis D; Moyssakis I; Perrea D; Kyriaki D; Katsilambros N
Metabolism; 2010 Feb; 59(2):159-65. PubMed ID: 19766273
[TBL] [Abstract][Full Text] [Related]
38. Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis.
Nishida M; Moriyama T; Ishii K; Takashima S; Yoshizaki K; Sugita Y; Yamauchi-Takihara K
Clin Chim Acta; 2007 Sep; 384(1-2):99-104. PubMed ID: 17618612
[TBL] [Abstract][Full Text] [Related]
39. Metabolic syndrome and C-reactive protein among cardiology patients.
Chapidze G; Dolidze N; Enquobahrie DA; Kapanadze S; Latsabidze N; Williams MA
Arch Med Res; 2007 Oct; 38(7):783-8. PubMed ID: 17845899
[TBL] [Abstract][Full Text] [Related]
40. Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome.
Guerrero-Romero F; Rodríguez-Morán M
Diabetes Metab Res Rev; 2006; 22(6):471-6. PubMed ID: 16598698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
